PRO OSTEON IMPLANT 500 POROUS HYDROXYAPATITE BONE GRAFT SUBSTITUTE BLOCKS & GRANULES

FDA Premarket Approval P860005 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for several labeling changes as identified and agreed upon in an april 17, 1998 facsimile of the labeling. The device name will also be modified and will be marketed under the trade name "pro osteon(r) implant 500 porous hydroxyapatite bone graft substitute blocks and granules. " the device is indicated for the repair of metaphyseal fracture defects and long bone cyst and tumor defects. For metaphyseal fracture defects, the device is indicated for treatment which occurs within one month of fracture. The device is to be used in conjunction with rigid internal fixation as dictated by the clinical use requirements in skeletally mature individuals.

DevicePRO OSTEON IMPLANT 500 POROUS HYDROXYAPATITE BONE GRAFT SUBSTITUTE BLOCKS & GRANULES
Generic NameFiller, Bone Void, Non-osteoinduction
ApplicantINTERPORE INTL.
Date Received1997-10-27
Decision Date1998-04-28
PMAP860005
SupplementS009
Product CodeMBS 
Advisory CommitteeOrthopedic
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address INTERPORE INTL. 181 Technology Dr. irvine, CA 92618-2402

Supplemental Filings

Supplement NumberDateSupplement Type
P860005Original Filing
S012 2001-12-04 Normal 180 Day Track
S011 1999-04-22 Normal 180 Day Track
S010 1997-11-18 Normal 180 Day Track
S009 1997-10-27 Normal 180 Day Track
S008 1997-08-28 Normal 180 Day Track
S007 1997-05-15 Normal 180 Day Track
S006
S005 1996-04-29 Normal 180 Day Track
S004 1994-02-22 Normal 180 Day Track
S003 1993-10-15 Normal 180 Day Track
S002 1993-03-23 Normal 180 Day Track
S001 1993-02-08 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.